Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine versus interferon beta in relapsing-remitting multiple sclerosis
2006-004937-13Phase 3Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Jul 2007
- Modality
- Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in multiple sclerosis (MS) comparing Azathioprine with Interferon beta (2 arms). Primary endpoint: Cumulative relapse count per patient over 2 years. Started Jul 2007; status: completed.
02
Drugs
azathioprineinterferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-004937-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004937-13.